Jefferies (JEF) says peak hiring and associated stock compensation expense are said to be behind the Co. now; bulk of large team hires is now complete
Newsquawk Staff ·
Jefferies (JEF) says peak hiring and associated stock compensation expense are said to be behind the Co. now; bulk of large team hires is now complete.
What it means
Guidance of this kind, an investment bank signalling that a hiring cycle and the deferred stock compensation attached to it have peaked, is read as a cost-base comment rather than a revenue one: the transmission is through the compensation-to-revenue ratio, the single largest expense line for the sector, and therefore through operating leverage into forward margins. In past episodes, banks making large team hires have absorbed an elevated comp ratio during the buildout, with the payoff framed as revenue share gains arriving with a lag; the recurring question is whether the promised productivity of the new teams materialises before the cost tail, since deferred awards typically vest and hit the P&L over several years after the hiring stops. Commentary that the bulk of hires is complete shifts attention from expense growth to whether revenues follow, which is what separates a successful capacity build from mere cost inflation in comparable cases. The follow-ons are the next quarterly comp ratio prints, any disclosure on revenue contribution from the new teams, and whether peers report similar pauses, which would mark an industry-wide turn in the talent war rather than a firm-specific one. As qualitative commentary rather than a formal guide, the signal is directional and depends on confirmation in reported numbers.
- US EQUITY OPEN: Tech outperforms amid risk-on trade as AI dip is bought
- Cleveland Cliffs (CLF) says currently selling steel in the best pricing environment in three years; adds that Q3 shipments increased and selling prices rose as expects, whilst costs beat guidance; this allowed Adj. EBITDA to more than double sequentially
- US White House NEC Director Hassett says inflation looks like it is needing some work, speaking on CNBC
- Kimberly-Clark (KMB) announces USD-denominated 5-parter: 2yr, 3yr, 5yr, 7yr, and 10yr, according to IFR
- Amazon (AMZN) invests in 1 GW nuclear project in Indiana, creating over 1,000 construction jobs and 100 permanent positions
Related headlines
- Anthropic has reportedly prepared a model that reads user intentions better, The Information reports28 min ago
- US BROKER MOVES: INTC upgraded at JPM; PYPL downgraded at Cleveland Research2 hours ago
- US PRE-MARKET MOVERS: SWKS, CRWV, OWL, CLF, INTC2 hours ago
- Johnson & Johnson (JNJ) to release 48‑week Tremfya data in Crohn’s disease2 hours ago
- Nscale official says they remain committed to both the Loughton project and the UK; are exploring alternative power sources for the site2 hours ago
- CoreWeave (CRWV) upgraded at Goldman Sachs to Buy; says NTM datapoints on contract economics are likely to be more positive than the market 2 hours ago
- Cleveland Cliffs (CLF) sees FY27 FCF at USD 2.7bln3 hours ago
- Tesla (TSLA) vehicles deliveries reach over 10mln; Model Y on track to be the best-selling vehicle this year of any kind3 hours ago
- Bristol‑Myers Squibb (BMY) to present oncology data at the ESMO conference3 hours ago
- KKR (KKR) confirms that it is to sell Infinity Transportation to Ares for USD 2.9bln 3 hours ago
- Fifth Third Bancorp (FITB) Q3 2026 (USD): Adj. EPS 1.13 (exp. 1.09), NII 2.27bln (exp. 2.27bln)3 hours ago
- JPMorgan (JPM) CEO Dimon says the US economy is booming4 hours ago
- KKR (KKR) to sell Infinity Transportation to Ares (ARES) for USD 2.9bln4 hours ago
- Cleveland Cliffs (CLF) Q3 2026 (USD): adj. EPS 0.28 (exp. 0.21), revenue 5.6bln (exp. 5.7bln)4 hours ago
- Eli Lilly's (LLY) Omvoh meets the primary endpoint of clinical remission in a Phase 3 paediatric ulcerative colitis trial, becoming the first IL-23p19 inhibitor to report one-year Phase 3 results in this patient population5 hours ago